Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial

IMPORTANCE: Dry eye disease (DED) is a common public health problem with significant impact on vision-related quality of life and well-being of patients. Medications with rapid onset of action and a good tolerability profile remain an unmet need. OBJECTIVE: To assess efficacy, safety, and tolerabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Akpek, Esen K., Wirta, David L., Downing, Johnathon E., Tauber, Joseph, Sheppard, John D., Ciolino, Joseph B., Meides, Alice S., Krösser, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080403/
https://www.ncbi.nlm.nih.gov/pubmed/37022717
http://dx.doi.org/10.1001/jamaophthalmol.2023.0709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080403/
https://www.ncbi.nlm.nih.gov/pubmed/37022717
http://dx.doi.org/10.1001/jamaophthalmol.2023.0709

Ejemplares similares